Change's Data Can't Be Used Anti-Competitively, Judge Told
An expert witness for UnitedHealth Group and Change Healthcare testified Friday there's no real risk the proposed $13.8 billion deal to buy Change would give a UHG subsidiary a leg up...To view the full article, register now.
Already a subscriber? Click here to view full article